Skip to content

Author

N. Mahajan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

LDL-C target achievement does not equal risk resolution after ACS: residual atherogenic and inflammatory burden despite maximal oral triple lipid therapy

Findings support moving beyond LDL-centric assessment toward particle-based phenotyping and provide a mechanistic rationale for early Lp(a)-targeted and anti-inflammatory therapeutic strategies.

K. Mahajan, N. Mahajan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.